QuickView for histone deacetylase regulator activity (biogroup)

1. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
2. Adipocyte profiling analyses of Selective PPARg Modulators and full PPARg agonists
3. Liver Pharmacology and Xenobiotic Response Repertoire
4. Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
5. Sarcoma and lung tumor cells treated with 5-aza-2-deoxyctidine/Trichostatin A or with IFN-g

There were no matches for histone deacetylase regulator activity

1. Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours
2. Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/…
3. Epigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome
4. Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
5. Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endo…